A98.0 Crimean-Congo hemorrhagic fever

Name of the Condition

• Crimean-Congo hemorrhagic fever (ICD-10 Code: A98.0)

Summary

Crimean-Congo hemorrhagic fever (CCHF) is a viral disease characterized by sudden onset of fever, bleeding, and potential organ failure. It is transmitted to humans through tick bites or contact with infected animal blood or tissues. The illness can range from mild to severe, with severe cases involving hemorrhagic manifestations and high mortality rates.

Causes

CCHF is caused by the Crimean-Congo hemorrhagic fever virus, a member of the Nairovirus genus in the Bunyaviridae family. The virus is primarily transmitted to humans through the bite of infected ticks, particularly of the Hyalomma species. Human-to-human transmission can occur through direct contact with blood, secretions, or tissues of infected individuals.

Risk Factors

• Exposure to tick-infested environments, especially in endemic regions.
• Occupational risks for farmers, slaughterhouse workers, or healthcare personnel handling infected animals or patients.
• Contact with blood or tissues of infected animals during butchering or processing.
• Lack of protective measures during tick exposure or patient care.

Symptoms

• Sudden onset of fever, chills, and severe headache.
• Muscle and joint pain, abdominal discomfort, and vomiting.
• Bleeding manifestations, including petechiae, bruising, or mucosal hemorrhage.
• In severe cases, shock, organ failure, or neurological symptoms may develop.

Diagnosis

Diagnosis is confirmed through laboratory testing, including reverse transcription polymerase chain reaction (RT-PCR) to detect viral RNA, antigen detection, or serological tests for antibodies. Samples must be handled under strict biosafety protocols due to the risk of transmission.

Treatment Options

• Supportive care: Focus on managing symptoms, such as fluid replacement, pain relief, and monitoring for bleeding or organ dysfunction.
• Antiviral therapy: Ribavirin may be used in severe cases, though evidence of efficacy is limited.
• Infection control: Strict isolation and barrier precautions to prevent human-to-human transmission.

Prognosis and Follow-Up

Prognosis depends on the severity of illness; severe cases have a high mortality rate. Survivors may experience prolonged recovery, and follow-up monitoring for complications or relapse is recommended. No long-term sequelae are typically reported.

Complications

• Severe hemorrhage leading to shock or organ failure.
• Secondary infections due to immunosuppression.
• Neurological complications in rare cases.

Lifestyle & Prevention

• Avoid tick bites by wearing protective clothing and using insect repellents in endemic areas.
• Practice safe handling of animal tissues or blood, especially during butchering.
• Implement strict infection control measures in healthcare settings to prevent transmission.
• Educate at-risk populations about symptoms and prevention strategies.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden fever, severe headache, or unexplained bleeding after potential exposure to ticks or infected animals. Prompt diagnosis and supportive care are critical for severe cases.

Tips for Medical Coders

• Use code A98.0 for confirmed cases of Crimean-Congo hemorrhagic fever.
• Document the source of infection (e.g., tick bite, animal contact) and clinical manifestations to support coding accuracy.
• Ensure laboratory confirmation is noted, as clinical diagnosis alone may not suffice for coding purposes.
• Differentiate from other viral hemorrhagic fevers when applicable, using specific codes only when criteria are met.